While these pharma stocks have steady cash flows and revenues, there’s still plenty of growth left in the tank from new drugs in development. These dividend-paying biotech stocks could be the best way to play the sector. Their dividends make them less volatile than the lotto tickets, but there’s still plenty of upside potential as well. And with the overall market down in the dumps, many of these strong dividend-paying biotech stocks are now trading for peanuts. That means investors have plenty of opportunities to score some great deals. With that, here are five dividend-paying biotech stocks you need to scoop up today...
There’s no denying that Amgen (NASDAQ:AMGN) is king of biotech stocks. Like Amgen, Gilead Sciences (NASDAQ:GILD) built its impressive dividend on the back of several key blockbuster drugs. At first blush, the next of our dividend stocks, French drug producer Sanofi (NYSE:SNY), looks more like a traditional pharmaceutical firm. Truth be told, Allergan (NYSE:AGN) could be the biggest bargain of any stock on this list. A big-time approval can do wonders for your future. Just ask AbbVie Inc. (NASDAQ:ABBV).
Source: InvestorPlace
Related Articles:
- Building Yield: 6 Consumer Goods Dividend Stocks
- Why Dividend Growth Stocks Are Evil
- 4 Higher-Yielding Financial Services Stocks With Rising Dividends
- 5 Higher Yield Dividend Growth Stocks
- Successful Investors Take The Emotion Out
________________________________________________________________
Subscribe to:
Post Comments (Atom)
Popular Posts Last 30 Days
-
Not all utility stocks are cut from the same cloth. There have been some dividend blow-ups in the sector, as a few have become over-leverage...
-
There are some dividend aristocrats which have not only maintained but increased their dividends for over half a century. Having survived ev...
-
Every investor needs a security blanket -- that piece of the portfolio that needs no attention and doesn't keep you up at night. Busines...
-
Showing resilience during a tough week was a group of stocks that has not been heard from much in the past two years. A group that has been ...
-
Just like stocks can be expensive, REITs can also be a bit pricey. But rather than use a price-to-earnings ratio, the best way to look at RE...
-
This REIT continues to make a strong value proposition for investors that value income stability in a volatile market. It convinces in terms...
-
Studies have shown that there is no single best season or month to trade stocks -- take that, January Effect! That said, there are some soli...
-
You have good reason to be nervous. Anyone who had just seen their retirement account take a big haircut would lose sleep. The question is, ...
-
In today’s market, high-yield stocks are usually not the safest bets. I mean, if a company is solid and offers a yield much higher than its ...
-
Most dividend stocks pay on a quarterly or even semi-annual basis. And while that may not seem like a problem, for many retirees used to a m...
0 comments
Post a Comment
Post a Comment